Evidence map›Paper›PMID 34789169›Full record

ArticleBMC bioinformatics2021

Drug-target interaction prediction using unifying of graph regularized nuclear norm with bilinear factorization.

Ali Ghanbari Sorkhi, Zahra Abbasi, Majid Iranpour Mobarakeh, Jamshid Pirgazi

Abstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ali Ghanbari SorkhiFaculty of Electrical and Computer Engineering, University of Science and Technology of Mazandaran, P.O. Box, 48518-78195, Behshahr, Iran. ali.ghanbari@mazust.ac.ir.
Zahra AbbasiSchool of Medicine, Faculty of Medical Biotechnology, Shahroud University of Medical Sciences, Shahroud, Iran.
Majid Iranpour MobarakehFaculty of Computer Engineering and IT, Payam Noor University, Tehran, Iran.
Jamshid PirgaziFaculty of Electrical and Computer Engineering, University of Science and Technology of Mazandaran, P.O. Box, 48518-78195, Behshahr, Iran. j.pirgazi@mazust.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWet-lab experiments for identification of interactions between drugs and target proteins are time-consuming, costly and labor-intensive. The use of computational prediction of drug-target interactions (DTIs), which is one of the significant points in drug discovery, has been considered by many researchers in recent years. It also reduces the search space of interactions by proposing potential interaction candidates.

resultsIn this paper, a new approach based on unifying matrix factorization and nuclear norm minimization is proposed to find a low-rank interaction. In this combined method, to solve the low-rank matrix approximation, the terms in the DTI problem are used in such a way that the nuclear norm regularized problem is optimized by a bilinear factorization based on Rank-Restricted Soft Singular Value Decomposition (RRSSVD). In the proposed method, adjacencies between drugs and targets are encoded by graphs. Drug-target interaction, drug-drug similarity, target-target, and combination of similarities have also been used as input.

conclusionsThe proposed method is evaluated on four benchmark datasets known as Enzymes (E), Ion channels (ICs), G protein-coupled receptors (GPCRs) and nuclear receptors (NRs) based on AUC, AUPR, and time measure. The results show an improvement in the performance of the proposed method compared to the state-of-the-art techniques.

Indexed as

AlgorithmsPharmaceutical PreparationsDrug DevelopmentDrug DiscoveryProteinsPharmaceutical PreparationsProteinsComputational predictionDrug discoveryDrug–target interactionLow-rank interaction

Identifiers

PMID34789169
PMCPMC8597250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.